New Paul Hopper Interview, page-16

Thank goodness any drug buy out will be negotiated by those who really know what those are worth, by IMU and big pharma.

If it was up to the market participants, OMG.

Everyone who got doubts due to the low sp, please listen to IMU's management, not to those who sold for 2c today or 1.9c at the close. IMU develops a variety of cancer prevention and fighting drugs. PH just confirmed it in the latest interview, the Prof to me last year and LC during a recent phone call.

Listen to what our Chair said about proof of concept and how that will change the following trials. They already anns POC. Even blind Freddy can see what IMU plus the acquired Ohio IP / drug developments have already achieved and proven. Just because our market is too blind or too stupid to realise the obvious it doesn't mean IMU is.

I can only guess what the sp should be or will be, but it won't be just 2c when the first drug gets sold to big pharma, which by the way has been declared as IMU's customers during the interview and in the top end result Ann's.

GLTA sufferers and holders.